By Editor , 19 September 2026 Alzamend Neuro Regains Nasdaq Listing Compliance With $5.8M Equity Atlanta – – September 18, 2026 -- Alzamend Neuro, Inc. (Nasdaq: ALZN) has regained compliance with Nasdaq's minimum stockholders' equity rule, ending a listing threat that began in March 2026.
